Sign in
4

Changes in Ownership

Syndax Pharmaceuticals Inc Filed Acc 0001562180-22-001079

Chief Scientific Officer sold 1,412 shares at $16.65 ($23,510)

  • Chief Scientific Officer acquired 1,412 shares (other)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ordentlich Peter Chief Scientific Officer 2022-01-31 Other acquisition +1,412 $12.39 $17,495 1,412 D: show line 1 in the form
Ordentlich Peter Chief Scientific Officer 2022-02-01 Sale −1,412 $16.65 $23,510 0 D: show line 2 in the form
Open-market sales · 1,412 sh · avg $16.65 · $23,510

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
Ordentlich Peter Chief Scientific Officer 2022-02-02 Grant or award · Stock Options (Right to buy) +80,000 $15.79 $1,263,200 80,000 D: show line 3 in the form
Loading xslF345X03/primarydocument.xml…